Plastic labware maker Tarsons India's first company to foray into Rs 24,000 crore global market for PCR, cell culture products

The company got approval from the capital market regulator SEBI on October 29 for the initial public offering. It will raise Rs 150 crore fresh capital, while 1.32 crore shares will be on offer for sale from promoters and a private equity investor.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3bAoOK1
via IFTTT